Clinical Trials Directory

Trials / Completed

CompletedNCT01256437

Evaluating Preventive Therapy With Oint Threolone, Synthomycine or Aqua Cream, for EGFR'I Induced Acneiform Rash

Double Blind Placebo Controlled Trial, for Evaluating Preventive Therapy With Either Oint Threolone Versus Synthomycine Versus Aqua Cream, for EGFR'I Induced Acneiform Rash

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Rabin Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.

Detailed description

The investigators hypothesized that topical anti-inflammatory treatment could counteract the inflammatory reaction induced by EGFR'Is.

Conditions

Interventions

TypeNameDescription
DRUGThreolone ointmentointment once daily for 1 month
DRUGointment Synthomycineointment once daily for 1 month
DRUGAqua creamointment once daily for 1 month

Timeline

Start date
2011-01-01
Primary completion
2017-01-01
Completion
2017-03-01
First posted
2010-12-08
Last updated
2017-05-09

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01256437. Inclusion in this directory is not an endorsement.